Current therapies for osteoarthritis and prospects of CRISPR-based genome,epigenome,and RNA editing in osteoarthritis treatment
作者机构:MOE Key Laboratory of Gene Function and RegulationState Key Laboratory of BiocontrolSchool of Life SciencesSun Yat-sen UniversityGuangzhouGuangdong 510275China Center for Reproductive MedicineThe Third Affiliated Hospital of Sun Yat-sen UniversitySun Yat-sen UniversityGuangzhouGuangdong 510630China
出 版 物:《Journal of Genetics and Genomics》 (遗传学报(英文版))
年 卷 期:2024年第51卷第2期
页 面:159-183页
核心收录:
学科分类:0710[理学-生物学] 1002[医学-临床医学] 100210[医学-外科学(含:普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学]
基 金:supported by the National Natural Science Foundation(32001063 and 82201769) the Guangdong Special Support Program(2019BT02Y276) the Guangdong Basic and Applied Basic Research Foundation(2021A1515010759 and 2023A1515010176) the grant from MOE Key Laboratory of Gene Function and Regulation,the Guangzhou Science and Technology Planning Project(202201020411 and 2023A04J1952) the Fundamental Research Funds for the Central Universities,Sun Yat-sen University(23ptpy59)
主 题:Osteoarthritis Genome editing Epigenone editing RNA editing
摘 要:Osteoarthritis(OA)is one of the most common degenerative joint diseases worldwide,causing pain,disability,and decreased quality of *** balance between regeneration and inflammation-induced degradation results in multiple etiologies and complex pathogenesis of ***,there is a lack of effective therapeutic strategies for OA *** the development of CRISPR-based genome,epigenome,and RNA editing tools,OA treatment has been improved by targeting genetic risk factors,activating chondrogenic elements,and modulating inflammatory *** by cell therapy and in vivo delivery vectors,genome,epigenome,and RNA editing tools may provide a promising approach for personalized OA *** review summarizes CRISPR-based genome,epigenome,and RNA editing tools that can be applied to the treatment of OA and provides insights into the development of CRISPR-based therapeutics for OA ***,in-depth evaluations of the efficacy and safety of these tools in human OA treatment are needed.